Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-25-026862
Filing Date
2025-07-23
Accepted
2025-07-23 09:22:45
Documents
3
Group Members
CONCENTRA BIOSCIENCES, LLCTANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A ef20052099_sctota.htm SC TO-T/A 34532
2 EXHIBIT (D)(6) ef20052099_ex99-d6.htm EX-99.D6 145189
3 image0.jpg GRAPHIC 29326
  Complete submission text file 0001140361-25-026862.txt   221960
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-92657 | Film No.: 251141839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3831
Concentra Merger Sub VI, Inc. (Filed by) CIK: 0002070890 (see all company filings)

EIN.: 392286336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A